Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Chemotherapy Options for Poor Responders to Neoadjuvant Chemotherapy for Orbital Granulocytic Sarcoma.

PropertyValue
has major subject area list Antineoplastic Combined Chemotherapy Protocols; Orbital Neoplasms; Sarcoma, Myeloid
has minor subject area list Biomarkers, Tumor; Combined Modality Therapy; Drug Resistance, Neoplasm; Humans; Molecular Targeted Therapy; Neoadjuvant Therapy; Recurrence; Retreatment; Treatment Failure; Treatment Outcome
information resource reference Gossai N, Cafferty R, Weigel B. Chemotherapy Options for Poor Responders to Neoadjuvant Chemotherapy for Orbital Granulocytic Sarcoma. Curr Treat Options Oncol. 2016 07; 17(7):38.
label Chemotherapy Options for Poor Responders to Neoadjuvant Chemotherapy for Orbital Granulocytic Sarcoma.

Search Criteria
  • Pharmacotherapy

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)